Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 4 pharmacokinetic study of oral posaconazole in adults with compromised gastrointestinal function at high risk for invasive fungal infection
2007-003148-31Phase 4Completed
- Sponsor
- Merck & Co.
- Start
- Sep 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of posaconazole in invasive mycoses, sponsored by Merck & Co. Primary endpoint: Mean plasma posaconazole concentration. Started Sep 2007; status: completed.
02
Drugs
posaconazole
03
Conditions
invasive mycoses
Beyond the preview
Go deeper on 2007-003148-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003148-31.